CFO4Life’s Merck MRK Stock Holding History

CFO4Life’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$792K	Buy	+7,136	New	+$729K	0.17%	71

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CFO4Life's MRK Position: Q4 2022 in Review

CFO4Life opened a new position in Merck (MRK) in Q4 2022: 7,136 shares worth $792K. The stake represents 0.17% of the portfolio and ranks #71 among its holdings.

3,236 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

CFO4Life held 7,136 shares of Merck worth $792K as of Q4 2022.
Merck was a new CFO4Life position in Q4 2022.
Merck made up 0.17% of CFO4Life's portfolio in Q4 2022, its #71 holding.
3,236 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on CFO4Life's 13F filing for Q4 2022, filed 11 Jan 2023.